Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Cancers|October 14, 2022
A Single Center Analysis of Thymic Neuroendocrine TumorsYirui Zhai, Qiang Zeng, Nan Bi, et al.
Thoracic Cancer|August 11, 2025
Efficacy and Safety of Afatinib Plus Bevacizumab as First-Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II TrialHuiyang Shi, Miaohan Wang, Junling Li, et al.
Journal of Hazardous Materials|September 13, 2025
Assessment of environmental and health impacts during 3D printing of candidate polymeric materials for space additive manufacturingJunling Li, Yi Liu, Chao Peng, et al.
Frontiers in Oncology|August 27, 2019
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung AdenocarcinomaXiaohong Han, Qiaoyun Tan, Sheng Yang, et al.
Plos One|November 25, 2015
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER studyYuankai Shi, Junling Li, Shucai Zhang, et al.
Journal of Cancer|June 18, 2019
The Efficacy of Upfront Intracranial Radiation with TKI Compared to TKI Alone in the NSCLC Patients Harboring EGFR Mutation and Brain MetastasesChunyu Wang, Xiaotong Lu, Zongmei Zhou, et al.
Theranostics|July 21, 2020
The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung AdenocarcinomaLu Yang, Jing Zhang, Guangjian Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Bcl-XL represents a druggable molecular vulnerability during aurora B inhibitor-mediated polyploidizationO Jameel Shah, Xiaoyu Lin, Leiming Li, et al.
Radiation Oncology (London, England)|March 29, 2022
Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaYirui Zhai, Bo Chen, Xiaoli Feng, et al.
The Oncologist|April 19, 2019
A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain MetastasesNan Bi, Yuchao Ma, Jianping Xiao, et al.
Pageof 32